LOBEF News and Press, Lobe Sciences Ltd From 04/25/22

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences , the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Co...

Lobe Sciences (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") is biotechnology company entering clinical stage development this year and is focused on transforming psychedelic medicine to benefit patients of all ages. Lobe is engaged in research and development using psychedelic and n...

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company'...

Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") announced today that Philip Young, CEO, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-V...

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) -  Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") today announced that Philip Young, CEO and Director, will present at the MONEYSHOW VIRTUAL EXPO, March 23 rd at 11:30AM EST. The presentatio...

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (the " Acquiror ") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 22, 2022 and February 23, 2022, it sold a total of 4...

Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - Lobe Sciences Ltd (CSE: LOBE) (OTCQB: LOBEF) today announced that Philip Young CEO will be attending the Q1 Virtual Investor Summit. During this presentation Lobe’s CEO Philip Young will provide highlights of the Co...

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Lobe Sciences Ltd. (the " Acquiror ") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 15, 2022, it sold 5,800,000 common shares in the capital of Ionic Brands Corp. (t...

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2022) - Lobe Sciences Ltd. (the " Acquiror ") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 11, 2022, it sold 8,000,000 common shares in the capital of Ionic Brands Corp. (t...

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Lobe Sciences Ltd. (the " Acquiror ") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 3, 2022, it acquired 47,065,647 common shares in the capital of Ionic Brands Corp....